BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 30, 2008
View Archived Issues
Recent patents report novel analgesic agents
Read More
New psychopharmacologic compounds disclosed in recent patents
Read More
Plethora completes patient recruitment into phase IIb study of PSD-508 for dysmenorrhea
Read More
MorphoSys completes first dosing regimen in phase I clinical trial of MOR-103
Read More
Medarex and Bristol-Myers present update on clinical development of ipilimumab
Read More
Solvay to acquire Innogenetics for EUR 177.6 million cash
Read More
Avesthagen and ShigaMedix enter agreement for vaccines against HPV and TB
Read More
Topically administered carbonic anhydrase specific siRNA improves intraocular pressure
Read More
Independent Pharmaceutica initiates phase II clinical trial of Niccine for nicotine dependence
Read More
Roxro reports positive results from proof-of-concept clinical study of ketorolac for migraine
Read More
Aida presents update on clinical development of Rh-Apo2L for cancer
Read More
Metabasis reports positive results from phase IIa clinical trial of MB-07803 in type 2 diabetes
Read More
IRC-083927 active in cells resistant to tubulin-binding agents
Read More
Neural stem cell-mediated treatment may allow targeted 5-FU therapy for glioma
Read More
Preclincal antitumor activity of CVX-060 increased by chemotherapy agents
Read More
Pfizer presents TP-10, a PDE10A inhibitor under development for schizophrenia
Read More
New agents for treating asthma and other respiratory disorders described in recent patent literature
Read More
Cougar initiates enrollment in phase III CB-7630 trial in prostate cancer
Read More
Merck receives not approvable letter from FDA for MK-0524A
Read More
Positive proof-of-concept data reported for Nuvelo's anticogulant NU-172
Read More
Orexo reports results from phase I study of OX-19 nasal spray for incontinence
Read More
KaloBios completes dosing in U.S. phase I clinical trial of monoclonal antibody KB-003
Read More
Inhibitex initiates phase I clinical trial of oral nucleoside analogue FV-100 for shingles
Read More
Cytokinetics commences second phase IIa CK-1827452 trial
Read More
Sucampo obtains FDA approval for Amitiza for IBS with constipation in adult women
Read More
Peregrine completes enrollment in first stage of phase II trial of bavituximab in breast cancer
Read More